Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With αvβ3-Integrin-Targeted Nanoparticles

Circulation

Volumn 108, Issue 18, 2003, Pages 2270-2274

  Winter, Patrick M ^a   Morawski, Anne M ^a   Caruthers, Shelton D ^a   Fuhrhop, Ralph W ^a   Zhang, Huiying ^a   Williams, Todd A ^a   Allen, John S ^a   Lacy, Elizabeth K ^a   Robertson, J David ^b   Lanza, Gregory M ^a   Wickline, Samuel A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Angiogenesis; Atherosclerosis; Contrast media; Magnetic resonance imaging

Indexed keywords

ALPHA5 INTEGRIN; BETA3 INTEGRIN; NANOPARTICLE;

ABDOMINAL AORTA; ADVENTITIA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT;

ANIMALS; AORTA; ARTERIOSCLEROSIS; CHOLESTEROL, DIETARY; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; MAGNETIC RESONANCE IMAGING; MALE; NEOVASCULARIZATION, PATHOLOGIC; PARTICLE SIZE; RABBITS; SENSITIVITY AND SPECIFICITY;

EID: 0242266976     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000093185.16083.95     Document Type: Article

References (22)

1. Zheng Z-J, Croft JB, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158-2163.
2. Carlier SG, de Korte CL, Brusseau E, et al. Imaging of atherosclerosis: elastography. J Cardiovasc Risk. 2002;9:237-245.
3. Unno N, Mitsuoka H, Takei Y, et al. Virtual angioscopy using 3-dimensional rotational digital subtraction angiography for endovascular assessment. J Endovasc Ther. 2002;9:529-534.
4. Madjid M, Naghavi M, Malik BA, et al. Thermal detection of vulnerable plaque. Am J Cardiol. 2002;90:36L-39L.
5. Demos S, Alkan-Onyuksel H, Kane B, et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol. 1999;33:867-875.
6. Tardif JC, Gregoire J, Schwartz L, et al. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation. 2003;107:552-558.
7. Kramer CM. Magnetic resonance imaging to identify the high-risk plaque. Am J Cardiol. 2002;90:15L-17L.
8. Fayad ZA, Fuster V, Nikolaou K, et al. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation. 2002;106:2026-2034.
9. Yuan C, Kerwin WS, Ferguson MS, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging. 2002;15:62-67.
10. Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation. 2003;107:851-856.
11. O'Brien ER, Garvin MR, Dev R, et al. Angiogenesis in human coronary atherosclerotic plaque. Am J Pathol. 1994;145:883-894.
12. Brooks PC, Montgomery AMP, Rosenfeld M, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157-1164.
13. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation. 2001;104:1280-1285.
14. Lanza G, Wallace K, Scott M, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. 1996;94:3334-3340.
15. Winter PM, Caruthers SD, Yu X, et al. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med. 2003;50:411-416.
16. Landsberger S. Delayed instrumental neutron activation analysis. In: Alfassi ZB, ed. Chemical Analysis by Nuclear Methods. New York, NY: Wiley; 1994:122-140.
17. Nappi J, Dachman A, MacEneaney P, et al. Automated knowledge-guided segmentation of colonic walls for computerized detection of polyps in CT colonography. J Comput Assist Tomogr. 2002;26:493-504.
18. Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999;99:1653-1655.
19. Wilson SH, Herrmann J, Lerman LO, et al. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation. 2002;105:415-418.
20. Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103:415-422.
21. Yu X, Song S-K, Chen J, et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med. 2000;44:867-872.
22. Lanza GM, Yu X, Winter PM, et al. Targeted antiproliferative drug delivery to vascular smooth muscle cells with an MRI nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation. 2002;106:2842-2847.